Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Travera Inc
AstraZeneca
NeoImmuneTech
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
SN BioScience
Cue Biopharma
Merck Sharp & Dohme LLC
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
AstraZeneca
Sichuan Enray Pharmaceutical Sciences Company
Alaunos Therapeutics
Novita Pharmaceuticals, Inc.
Celldex Therapeutics
NGM Biopharmaceuticals, Inc
Esperas Pharma Inc.
Exelixis
Laval University
Labcorp Corporation of America Holdings, Inc
Stanford University
Lindis Bloodcare GmbH
Purple Biotech Ltd.
Cyteir Therapeutics, Inc.
Taproot Health
Acepodia Biotech, Inc.
Eli Lilly and Company
Astellas Pharma Inc
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Stanford University
DxTerity Diagnostics
Xencor, Inc.
Cedars-Sinai Medical Center
University Medical Center Groningen
Exelixis
Sanguine Biosciences
AstraZeneca
Eli Lilly and Company
Celldex Therapeutics
ZielBio, Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Pfizer
Corvus Pharmaceuticals, Inc.
The Canadian College of Naturopathic Medicine
M.D. Anderson Cancer Center